Regional protein expression in human Alzheimer’s brain correlates with disease severity

Jingshu Xu(Manchester Academic Health Science Centre), Stefano Patassini(Manchester Academic Health Science Centre), Nitin Rustogi(Manchester Academic Health Science Centre), Isabel Riba‐Garcia(Manchester Academic Health Science Centre), Benjamin D. Hale(Manchester Academic Health Science Centre), Alexander M. Phillips(University of Liverpool), Henry J. Waldvogel(University of Auckland), Robert Haines(University of Manchester), Phil Bradbury(University of Manchester), Adam Stevens(Manchester Academic Health Science Centre), Richard L. M. Faull(University of Auckland), Andrew W. Dowsey(Manchester Academic Health Science Centre), Garth J. S. Cooper(University of Auckland), Richard D. Unwin(Manchester Academic Health Science Centre)
Communications Biology
February 4, 2019
Cited by 189Open Access
Full Text

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that currently affects 36 million people worldwide with no effective treatment available. Development of AD follows a distinctive pattern in the brain and is poorly modelled in animals. Therefore, it is vital to widen the spatial scope of the study of AD and prioritise the study of human brains. Here we show that functionally distinct human brain regions display varying and region-specific changes in protein expression. These changes provide insights into the progression of disease, novel AD-related pathways, the presence of a gradient of protein expression change from less to more affected regions and a possibly protective protein expression profile in the cerebellum. This spatial proteomics analysis provides a framework which can underpin current research and open new avenues to enhance molecular understanding of AD pathophysiology, provide new targets for intervention and broaden the conceptual frameworks for future AD research.


Related Papers

No related papers found

Powered by citation graph analysis